Dr. Michael Greger is famous for several books including “How Not to Die,” and for his website nutritionfacts.org. He ...

Originally developed to treat Type 2 diabetes, glucagon-like peptide 1 (GLP-1s) are now being studied to explore their ...

Premca Capital, which has a small stake in Weight Watchers parent company WW International (NASDAQ:WW) is seeking seats on its board as well as cost cuts totalling hundreds of millions of dollars, The ...

The rise of GLP-1 drugs like Ozempic are changing consumer food waste patterns both at home and in restaurant settings.

Eli Lilly (LLY) leads with groundbreaking tirzepatide (Mounjaro/Zepbound), while Hims & Hers Health (HIMS) faces challenges.

Hone Health reports that, when it comes to slowing aging and extending lifespan, few interventions are as well-supported by ...

Ozempic was once just another prescription drug in a commercial featuring athletic, happy people. Now, it’s everywhere, and ...

Hims & Hers is expanding access to Eli Lilly's branded weight loss drug Zepbound and diabetes drug Mounjaro as well as ...

The recent uptick and rise in popularity of GLP-1 drugs for addressing weight loss and obesity has led to an increase in U.S. litigation ...

Love Is Blind star, Chelsea Blackwell, has credited injectable drug, GLP-1, for her major weight loss transformation.

In today’s fast-paced world, achieving better health outcomes is more crucial than ever. We’re witnessing a growing movement where local communities are coming together, leveraging innovative tools ...

CEO Sean Connolly highlighted that Q3 performance aligned with expectations, with strong brand resilience and consumption trends despite supply chain constraints, particularly in frozen meals with ...